Ocular Coherence Tomography During Cataract Assessment
Importance of Ocular Coherence Tomography During Cataract Assessment
1 other identifier
observational
626
1 country
1
Brief Summary
Many patients will have underlying maculopathy present when undergoing cataract surgery, which are not visible on fundoscopy alone. Knowledge of this underlying pathology will allow an improved consenting process and discussion with the patient regarding the risks, visual prognosis and recovery following cataract surgery. Incidental findings in the fellow eye would also allow for improved diagnosis and management of these patients without adding significant additional time to specialist high volume cataract assessment clinics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 6, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2020
CompletedFirst Submitted
Initial submission to the registry
March 10, 2022
CompletedFirst Posted
Study publicly available on registry
March 18, 2022
CompletedNovember 3, 2023
November 1, 2023
4 days
March 10, 2022
November 2, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of occult macular pathologies in the eye referred for cataract surgery
Comparison of slitlamp biomicroscopy fundus finding with ocular coherence tomography (OCT) scan of the macula
During the cataract assessment clinic
Secondary Outcomes (1)
Incidence of macular pathologies in the fellow eye
During the cataract assessment clinic
Interventions
OCT images were recorded as a fast macular radial line scan with captured on either Heidelberg Spectralis (Heidelberg Engineering GmbH, Germany) or Topcon DRI Triton (Topcon Medical Systems inc. USA).
Eligibility Criteria
This was a prospective cross-sectional study of 626 consecutive patients attending cataract assessment clinics at the Sussex Eye Hospital between 2/11/20 and 6/11/20. \]As part of work to decrease waiting times for patients in the wake of the first wave of COVID-19 pandemic and the shutdown of non-emergency services, a week of activity dedicated to cataract assessment was undertaken at Brighton \& Sussex University Hospitals NHS trust between 2nd and 6th November 2020.
You may qualify if:
- Patients referred for cataract surgery
You may not qualify if:
- Patients unable to attend the cataract assessment clinic
- Morbid patients who cannot be assessed on OCT or slit lamp
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Brighton & Sussex University Hospitals NHS Trust
Brighton, Sussex, BN2 5BF, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 10, 2022
First Posted
March 18, 2022
Study Start
November 2, 2020
Primary Completion
November 6, 2020
Study Completion
November 30, 2020
Last Updated
November 3, 2023
Record last verified: 2023-11